Biocartis expands collaboration with LifeArc
Mechelen, Belgium, and London, UK, 1 September 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an…
We've helped establish a successful relationship between @MRC_LMB, two universities and a global pharmaceutical com… https://t.co/tViUZRG7P2
LifeArc appoints Dr Ian Campbell as Chief Business Officer
Former Innovate UK Executive Chair joins charity to drive new collaborations and partnerships to benefit patient health.
LifeArc appoints Clare Terlouw to lead its life sciences investment strategy
Clare will be responsible for LifeArc’s investments across the life science sector
KQ Labs opens accelerator programme and announces LifeArc as a strategic partner
KQ Labs is now accepting applications for its third cohort of companies. Early stage data-driven health companies…
LifeArc backs 15 patient studies into ‘re-purposed’ therapies to fight coronavirus
£10m in grants mean patient enrolment can begin immediately
LifeArc and MRC partnership creates new £16m fund to establish Gene Therapy Innovation Hubs
Hubs aim to address challenges in progressing novel gene therapy research into early stage clinical trials
LifeArc provides £2m to the University of Edinburgh STOPCOVID initiative
LifeArc provides £2m to the STOPCOVID project, which aims to test existing and experimental drugs to find a treatment for COVID-19
LifeArc launches £10 million research fund to address the challenges of COVID-19
Today, LifeArc, a UK-based medical research charity, has created a £10 million fund to support research to…
LifeArc announces seed fund investment in start-up GyreOx
The funding will support a two-year programme to develop and automate GyreOx’s proprietary drug discovery platform, MACRO.